Posts With Tag NASDAQ BBIO

Showing 1 - 2 of 2 Posts

BridgeBio Pharma, Inc. 8-K Filing Report: Key Updates for Investors

•

Form 8-K

•

2025-02-20

Last updated: 3 months ago

BridgeBio Pharma, Inc. 8-K Filing Report: Key Updates for Investors

Explore BridgeBio Pharma, Inc.'s 8-K filing from February 20, 2025. Discover vital updates on corporate changes and events affecting BBIO stock. Stay informed!

BridgeBio Pharma Biotechnology NASDAQ BBIO 8-K Filing Corporate Finance

BridgeBio Pharma, Inc. Form 8-K Report: Key Insights & Corporate Updates

•

Form 8-K

•

2025-01-13

Last updated: 4 months ago

BridgeBio Pharma, Inc. Form 8-K Report: Key Insights & Corporate Updates

Explore BridgeBio Pharma, Inc.'s latest Form 8-K filing dated January 13, 2025, highlighting essential corporate updates and stock information crucial for investors.

BridgeBio Pharma biopharmaceuticals NASDAQ BBIO Form 8-K corporate compliance